Mast Therapeutics Inc. (NYSEMKT:MSTX) Up 5.80%, Vantage Drilling Company (NYSEMKT:VTG) Up 5.52%
Northern, WI 05/27/2013 (GDPInsider) – Mast Therapeutics Inc. (NYSEMKT:MSTX) opened trading today at 0.67, 0.03 cents above its previous close of 0.69. The stock is up 5.80% in today’s market valuation and has a range of 0.66 and 0.74. MSTX is trading 20.65% below its 52-week high of 0.92 and 62.22% above its 52-week low of 0.45. Volume today is 614,021, 159.25% above average volume of 236,845. MSTX’s technical chart shows fluctuating movement with most recent trading trending upwards towards its first resistance point of 0.76. Since June 2012 MSTX has gained 62.22% on its 52-week low.
The company is coming off its first quarter 2013 financial results in which MSTX disclosed a net loss of $5.6 million, or $0.12 per share. This net loss represents an increase upon losses posted in the corresponding quarter 2012 of $4.2 million.
MSTX is trading 8.87% above its 20-day simple moving average and 7.89% above its 50-day simple moving average. The stock has a target price of 3.00 and a RSI of 62.94.
Is MSTX a solid investment at these levels? Get exclusive data and trends here.
Vantage Drilling Company (NYSEMKT:VTG) is up 5.52% after starting the day’s trading at 1.81, level with the previous day’s close. The stock is trading on strong volume of 1.987 million and has a range of 1.80 and 1.93. Average volume is 872.28K and VTG has a 52-week range of 1.32 and 1.95. Current valuation has placed VTG 2.05% below its 52-week high and 44.70% above its 52-week low. VTG’s technical chart shows an uptrend with a northward slope; this has prevailed since mid-May 2013 and is consistent with VTG’s key moving average indicators.
On May 10, 2013 VTG released its financial results for the quarter ended March 31, 2013. The company reported revenues of $147.0 million, a shave below analyst expectations of $147.1 million. VTG bettered GAAP reported sales for Q1 2012 with a 28% increase. The company reported a gross margin of 45.4% — 980 basis points better than Q1 2012 and operating margin was 28.6%.
VTG is trading 12.12% above its SMA20 and 12.88% above its SMA50. Analysts have set a target price of 2.28 and VTG is presently overbought with a RSI of 71.74.
How Should Investors Trade VTG Now? Get exclusive insights and updates here.
WallStreetAnalyzed.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetAnalyzed.com website, for complete risks and disclosures.